Natural History of Patients With PH3 and a History of Stone Events

Clinical trial NCT04542590 · COMPLETED

Trial details

NCT number: NCT04542590
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Status: COMPLETED
Study type: OBSERVATIONAL

Primary Hyperoxaluria Type 3

Start date: 2021-09-09
Primary completion: 2024-07-23
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.